A new Northwestern Medicine study shows antibodies generated by prior vaccinations or infections can actually “hurt” subsequent COVID-19 booster shots.
Targeting calcium signaling in neurons may represent a promising therapeutic approach for treating a rare form of schizophrenia, according to a Northwestern Medicine study.
Northwestern scientists have created the first highly mature neurons from human induced pluripotent stem cells, a feat that opens new opportunities for medical research and potential transplantation therapies for neurodegenerative diseases.
A new Northwestern Medicine study has discovered the role of cerebrospinal fluid in cognitive impairment, such as Alzheimer’s disease.
Genetic testing in epilepsy patients can inform treatment and lead to better outcomes in many cases, according to a study published in JAMA Neurology.
Northwestern physicians, scientists and people living with ALS gathered at the 12th annual Les Turner Symposium on ALS to share knowledge and celebrate advances in understanding and treating the disease.
Investigators have discovered novel genetic factors that contribute to the risk of Parkinson’s disease, according to a recent Northwestern Medicine study.
After 28 years of leadership, M. Marsel Mesulam, MD, has announced that he will be stepping down as director of the Mesulam Center for Cognitive Neurology and Alzheimer’s Disease; he will be succeeded by Robert Vassar, PhD.
Northwestern Medicine investigators have discovered that outer mitochondrial membrane proteins regulate crosstalk between mitochondria and lysosomes, findings that have implications for many diseases.
Dimitri Krainc, MD, PhD, chair and Aaron Montgomery Ward Professor of Neurology, has been elected to the National Academy of Medicine.